Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients

Condition:   Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Intervention:   Sponsors:   Royal Marsden NHS Foundation Trust;   Janssen, LP Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials